A study on the relevance between sleep apnea syndrome and heart failure in non-obstructive hypertrophic cardiomyopathy with left ventricular function maintained - NHOC-HCM

ational Hospital Organization Yokohama Medical Center0 sites200 target enrollmentMarch 14, 2019

Overview

No summary available.

Registry

who.int

Start Date

March 14, 2019

End Date

March 31, 2025

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

ational Hospital Organization Yokohama Medical Center

•(1\) Having treated by oral appliance (OA), CPAP, Adaptive Servo\-Ventilation (ASV), Bi\-level positive airway pressure (BiPAP), and surgical treatment at the time of registration (2\)Diagnosed with secondary myocardial hypertrophy such as Fabry disease (3\) Hospitalized for decompensated heart failure at registration (4\)Undergoing ventricular resynchronization therapy (Cardiac Resynchronization Therapy: CRT) (5\) With a history of open heart surgery such as artificial valve replacement surgery accompanying pericardiotomy (6\)With left ventricular outflow tract gradient \>\= 30 mmHg (7\) With dilated hypertrophic cardiomyopathy (defined as with left ventricular ejection fraction \<40%) (8\)With malignant tumor complications (9\)Judged by the attending physician as inappropriate to participate in this study due to chronic hepatitis or cirrhosis (10\) Same as above, except due to pulmonary fibrosis accompanied by elevation of either KL\-6, SP\-D or SP\-A (11\) Same as above, except due to rheumatoid arthritis (12\)Judged by the principal investigator or sub\-investigators as inappropriate for participation in this study